At the news
? NEUTRALIMPACT 2/10 144 filed Nov 4, 2026 at 16:02 ET
Jason Pitofsky, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 3,883 shares of common stock via cashless exercise of stock options granted in 2020, 2021, and 2022. The shares are valued at approximately $3.79 million based on the filing date, representing a small fraction of the company's $99.4 billion market cap.
- Jason Pitofsky, an officer of Regeneron, filed a Form 144 on November 4, 2026
- The filing covers 3,883 shares of common stock
- Shares are to be sold via cashless exercise of stock options granted on 12/09/2020 (905 shares), 12/08/2021 (1,478 shares), and 12/16/2022 (1,500 shares)
- The approximate market value of the shares is $3,789,808
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access